157 related articles for article (PubMed ID: 18424416)
61. Genetic variants in MicroRNA biosynthesis pathways and binding sites modify ovarian cancer risk, survival, and treatment response.
Liang D; Meyer L; Chang DW; Lin J; Pu X; Ye Y; Gu J; Wu X; Lu K
Cancer Res; 2010 Dec; 70(23):9765-76. PubMed ID: 21118967
[TBL] [Abstract][Full Text] [Related]
62. MMP-2 geno-phenotype is prognostic for colorectal cancer survival, whereas MMP-9 is not.
Langers AM; Sier CF; Hawinkels LJ; Kubben FJ; van Duijn W; van der Reijden JJ; Lamers CB; Hommes DW; Verspaget HW
Br J Cancer; 2008 Jun; 98(11):1820-3. PubMed ID: 18506186
[TBL] [Abstract][Full Text] [Related]
63. ESR1/SYNE1 polymorphism and invasive epithelial ovarian cancer risk: an Ovarian Cancer Association Consortium study.
Doherty JA; Rossing MA; Cushing-Haugen KL; Chen C; Van Den Berg DJ; Wu AH; Pike MC; Ness RB; Moysich K; Chenevix-Trench G; Beesley J; Webb PM; Chang-Claude J; Wang-Gohrke S; Goodman MT; Lurie G; Thompson PJ; Carney ME; Hogdall E; Kjaer SK; Hogdall C; Goode EL; Cunningham JM; Fridley BL; Vierkant RA; Berchuck A; Moorman PG; Schildkraut JM; Palmieri RT; Cramer DW; Terry KL; Yang HP; Garcia-Closas M; Chanock S; Lissowska J; Song H; Pharoah PD; Shah M; Perkins B; McGuire V; Whittemore AS; Di Cioccio RA; Gentry-Maharaj A; Menon U; Gayther SA; Ramus SJ; Ziogas A; Brewster W; Anton-Culver H; ; ; Pearce CL;
Cancer Epidemiol Biomarkers Prev; 2010 Jan; 19(1):245-50. PubMed ID: 20056644
[TBL] [Abstract][Full Text] [Related]
64. Association between kinase insert domain-containing receptor polymorphisms (-604T>C, 1192G>A, 1719A>T) and premature ovarian failure in Korean women.
Rah H; Jeon YJ; Choi Y; Shim SH; Ko JJ; Yoon TK; Cha SH; Kim NK
Menopause; 2012 Sep; 19(9):1037-42. PubMed ID: 22510937
[TBL] [Abstract][Full Text] [Related]
65. Contribution of Matrix Metalloproteinase-2 Genotypes to Taiwan Pterygium Risk.
Hu PS; Hsia NY; Wang ZH; Chen HC; Hsia TC; Lin ML; Wang YC; Chang WS; Bau DT; Tsai CW
In Vivo; 2024; 38(2):539-545. PubMed ID: 38418145
[TBL] [Abstract][Full Text] [Related]
66. Tissue inhibitor of metalloproteinases-1, -2, and -3 polymorphisms in a white population with intracranial aneurysms.
Krex D; Röhl H; König IR; Ziegler A; Schackert HK; Schackert G
Stroke; 2003 Dec; 34(12):2817-21. PubMed ID: 14605322
[TBL] [Abstract][Full Text] [Related]
67. Association between common germline genetic variation in 94 candidate genes or regions and risks of invasive epithelial ovarian cancer.
Quaye L; Tyrer J; Ramus SJ; Song H; Wozniak E; DiCioccio RA; McGuire V; Høgdall E; Høgdall C; Blaakaer J; Goode EL; Schildkraut JM; Easton DF; Krüger-Kjaer S; Whittemore AS; Gayther SA; Pharoah PD
PLoS One; 2009 Jun; 4(6):e5983. PubMed ID: 19543528
[TBL] [Abstract][Full Text] [Related]
68. Effects of
Wu PL; Ling XC; Kang EY; Chen KJ; Wang NK; Liu L; Chen YP; Hwang YS; Lai CC; Yang SF; Wu WC
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430677
[TBL] [Abstract][Full Text] [Related]
69. Genetic variants in matrix metalloproteinase-9 gene modify metalloproteinase-9 levels in black subjects.
Metzger IF; Luizon MR; Lacchini R; Tanus-Santos JE
DNA Cell Biol; 2012 Apr; 31(4):504-10. PubMed ID: 21936677
[TBL] [Abstract][Full Text] [Related]
70. Association of single nucleotide polymorphisms in glycosylation genes with risk of epithelial ovarian cancer.
Sellers TA; Huang Y; Cunningham J; Goode EL; Sutphen R; Vierkant RA; Kelemen LE; Fredericksen ZS; Liebow M; Pankratz VS; Hartmann LC; Myer J; Iversen ES; Schildkraut JM; Phelan C
Cancer Epidemiol Biomarkers Prev; 2008 Feb; 17(2):397-404. PubMed ID: 18268124
[TBL] [Abstract][Full Text] [Related]
71. Matrix metalloproteinase-2 polymorphisms and breast cancer susceptibility.
Beeghly-Fadiel A; Lu W; Long JR; Shu XO; Zheng Y; Cai Q; Gao YT; Zheng W
Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1770-6. PubMed ID: 19454611
[TBL] [Abstract][Full Text] [Related]
72. Association between the -1306C/T polymorphism of matrix metalloproteinase-2 gene and lumbar disc disease in Chinese young adults.
Dong DM; Yao M; Liu B; Sun CY; Jiang YQ; Wang YS
Eur Spine J; 2007 Nov; 16(11):1958-61. PubMed ID: 17680282
[TBL] [Abstract][Full Text] [Related]
73. AXIN2 polymorphism and its association with prostate cancer in a Turkish population.
Pinarbasi E; Gunes EG; Pinarbasi H; Donmez G; Silig Y
Med Oncol; 2011 Dec; 28(4):1373-8. PubMed ID: 21069480
[TBL] [Abstract][Full Text] [Related]
74. Tissue inhibitor of metalloproteinase-1 (TIMP-1) polymorphisms in a Caucasian population with abdominal aortic aneurysm.
Hinterseher I; Krex D; Kuhlisch E; Schmidt KG; Pilarsky C; Schneiders W; Saeger HD; Bergert H
World J Surg; 2007 Nov; 31(11):2248-54. PubMed ID: 17899257
[TBL] [Abstract][Full Text] [Related]
75. Genotype association of C(-735)T polymorphism of the MMP-2 gene with the risk of carotid atherosclerosis-vulnerable plaque in the Han Chinese population.
Wang F; Jin XP; Zhu M; Lin XF; Hu XF; Wang WF; Han Z; Huang LZ
Vasc Med; 2011 Feb; 16(1):13-8. PubMed ID: 21471148
[TBL] [Abstract][Full Text] [Related]
76. The influence of matrix metalloproteinase-2, -9, and -12 promoter polymorphisms on Iranian patients with oesophageal squamous cell carcinoma.
Eftekhary H; Ziaee AA; Yazdanbod M; Shahpanah M; Setayeshgar A; Nassiri M
Contemp Oncol (Pozn); 2015; 19(4):300-5. PubMed ID: 26557778
[TBL] [Abstract][Full Text] [Related]
77. Association of two common single-nucleotide polymorphisms in the CYP19A1 locus and ovarian cancer risk.
Goodman MT; Lurie G; Thompson PJ; McDuffie KE; Carney ME
Endocr Relat Cancer; 2008 Dec; 15(4):1055-60. PubMed ID: 18667686
[TBL] [Abstract][Full Text] [Related]
78. Interleukin-18 gene promoter and serum level in women with ovarian cancer.
Samsami Dehaghani A; Shahriary K; Kashef MA; Naeimi S; Fattahi MJ; Mojtahedi Z; Ghaderi A
Mol Biol Rep; 2009 Nov; 36(8):2393-7. PubMed ID: 19263242
[TBL] [Abstract][Full Text] [Related]
79. Association of lipopolysaccharide-binding protein gene polymorphisms with cerebral infarction in a Chinese population.
Zhan Q; Yuan M; Wang XH; Duan XM; Yang QD; Xia J
J Thromb Thrombolysis; 2012 Aug; 34(2):260-8. PubMed ID: 22476641
[TBL] [Abstract][Full Text] [Related]
80. Genetic polymorphisms in the estrogen receptor beta (ESR2) gene and the risk of epithelial ovarian carcinoma.
Lurie G; Wilkens LR; Thompson PJ; McDuffie KE; Carney ME; Terada KY; Goodman MT
Cancer Causes Control; 2009 Feb; 20(1):47-55. PubMed ID: 18704709
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
